OQS
WST icon

Occudo Quantitative Strategies’s West Pharmaceutical WST Stock Holding History

Occudo Quantitative Strategies’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-14,825
Closed -$3.65M – 1424
2022
Q3 		$3.65M Buy
+14,825
New +$4.52M 0.28% 72
2021
Q2 		– Sell
-4,553
Closed -$1.28M – 1076
2021
Q1 		$1.28M Sell
4,553
-52
-1% -$14.9K 0.28% 85
2020
Q4 		$1.3M Buy
+4,605
New +$1.29M 0.41% 31

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Occudo Quantitative Strategies's WST Position: Q4 2022 in Review

Occudo Quantitative Strategies sold out of West Pharmaceutical (WST) in Q4 2022, closing a stake of 14,825 shares — an estimated $3.65M sold.

Occudo Quantitative Strategies first reported a position in WST in Q4 2020 and held it in 3 quarters. The position peaked at $3.65M in Q3 2022. 637 funds tracked by Wall St. Rank hold WST as of Q4 2022.

  • Occudo Quantitative Strategies reported no remaining West Pharmaceutical position as of Q4 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 14,825 West Pharmaceutical shares in Q4 2022, an estimated $3.65M.
  • Occudo Quantitative Strategies first reported a position in West Pharmaceutical in Q4 2020 and held it in 3 quarters.
  • Occudo Quantitative Strategies's West Pharmaceutical position peaked at $3.65M in Q3 2022.
  • 637 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.